Archimedes Pharma, which has submitted an NDA for its lead product, PecFent fentanyl nasal spray, announced that it anticipates creating as many as 75 new jobs at its new US headquarters in Bedminster, NJ. The company's main headquarters are in Reading, UK. Read the company's press release. … [Read more...] about Archimedes to open US headquarters in New Jersey
News
MannKind announces $110 million stock agreement
MannKind Corporation, which is waiting for FDA approval of its Afrezza inhaled insulin, announced that it hopes to raise up to $110 million by lending 9 million shares of its stock to Bank of America. Merrill Lynch will then sell the borrowed shares, shorting the stock, and will use the proceeds in conjunction with a private offering of MannKind Senior Convertible … [Read more...] about MannKind announces $110 million stock agreement
Cannabis Science and Smokefree Innotec sign development agreement
Cannabis Science and Smokefree Innotec will co-develop pharmaceutical cannabis products for inhalation. Smokefree Innotec, which manufactures electronic cigarettes, will develop the devices, with Cannabis Science developing the formulations. Read the company's press release … [Read more...] about Cannabis Science and Smokefree Innotec sign development agreement
Alexza hires new VP, Quality
Alexza has hired Darl Moreland as its new Vice President, Quality. Moreland was previously VP, Quality Assurance and Compliance and Chief Compliance officer for Mentor Worldwide. At Alexza, he will be responsible for quality assurance, quality control, and quality system regulatory compliance. Read the company's press release. … [Read more...] about Alexza hires new VP, Quality
Acetaminophen (paracetamol) doubles asthma risk
A study published in the American Journal of Respiratory and Critical Care Medicine found that teenagers who used acetaminophen at least once a month have a 250% higher risk of developing asthma than do non-users and nearly as great an increased risk of developing rhinoconjunctivitis. Read the abstract. … [Read more...] about Acetaminophen (paracetamol) doubles asthma risk
RTS announces new US Headquarters
RTS Life Sciences has formed RTL Life Science LLC, based near Boston, MA. RTS manufactures automated inhaler testing systems. Read the company's press release. … [Read more...] about RTS announces new US Headquarters
GSK licenses DPI formulation technology from Vectura
Vectura will license dry powder formulation technology to GlaxoSmithKline for use in respiratory products for up to £20 million. The deal is for worldwide rights and is non-exclusive. Read the company's press release. … [Read more...] about GSK licenses DPI formulation technology from Vectura